According to Charles River Laboratories 's latest financial reports the company's current revenue (TTM) is $4.12 B. In 2022 the company made a revenue of $3.97 B an increase over the years 2021 revenue that were of $3.54 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $4.12 B | 3.86% |
2022 | $3.97 B | 12.31% |
2021 | $3.54 B | 21.08% |
2020 | $2.92 B | 11.55% |
2019 | $2.62 B | 15.67% |
2018 | $2.26 B | 21.99% |
2017 | $1.85 B | 10.48% |
2016 | $1.68 B | 23.34% |
2015 | $1.36 B | 5.06% |
2014 | $1.29 B | 11.34% |
2013 | $1.16 B | 3.19% |
2012 | $1.12 B | -1.15% |
2011 | $1.14 B | 2.05% |
2010 | $1.11 B | -6.89% |
2009 | $1.20 B | -10.49% |
2008 | $1.34 B | 9.17% |
2007 | $1.23 B | 16.27% |
2006 | $1.05 B | -2.87% |
2005 | $1.08 B | 42.09% |
2004 | $0.76 B | 24.96% |
2003 | $0.61 B | 10.65% |
2002 | $0.55 B | 19.11% |
2001 | $0.46 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $42.85 B | 937.85% | ๐บ๐ธ USA |
SCYNEXIS SCYX | $0.14 B | -96.61% | ๐บ๐ธ USA |
Repligen
RGEN | $0.60 B | -85.29% | ๐บ๐ธ USA |